These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 15022439

  • 1. ["I-125 Rapid-Strand" interstitial radiotherapy of localised prostate cancer].
    Sivkov AV, Oshchepkov VN, Pataki KV, Obukhova TV.
    Urologiia; 2004; (1):21-5. PubMed ID: 15022439
    [Abstract] [Full Text] [Related]

  • 2. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.
    Hiratsuka J, Jo Y, Yoshida K, Nagase N, Fujisawa M, Imajo Y.
    Int J Radiat Oncol Biol Phys; 2004 Jul 01; 59(3):684-90. PubMed ID: 15183471
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prostate-specific antigen relapse-free survival in patients with localized prostate cancer treated by brachytherapy.
    Joseph J, Al-Qaisieh B, Ash D, Bottomley D, Carey B.
    BJU Int; 2004 Dec 01; 94(9):1235-8. PubMed ID: 15610096
    [Abstract] [Full Text] [Related]

  • 5. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
    Momma T, Saito S, Toya K, Yorozu A, Dokiya T, Murai M.
    Int J Urol; 2006 Mar 01; 13(3):218-23. PubMed ID: 16643612
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Four-year experience of interstitial permanent brachytherapy for Japanese men with localized prostate cancer.
    Ishiyama H, Satoh T, Kitano M, Tsumura H, Kotani S, Okusa H, Uemae M, Baba S, Hayakawa K.
    Jpn J Clin Oncol; 2008 Jul 01; 38(7):469-73. PubMed ID: 18577509
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Brachytherapy boost irradiation in the treatment of high risk, localised prostate cancer. Initial national experience in Hungary].
    Agoston P, Major T, Somogyi A, Szûcs M, Danczig A, Lövey J, Polgár C, Fodor J, Németh G, Kásler M.
    Magy Onkol; 2004 Jul 01; 48(1):81-8. PubMed ID: 15105901
    [Abstract] [Full Text] [Related]

  • 11. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.
    Ho AY, Burri RJ, Cesaretti JA, Stone NN, Stock RG.
    Int J Radiat Oncol Biol Phys; 2009 Sep 01; 75(1):16-22. PubMed ID: 19289266
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The impact of hormone therapy on post-implant dosimetry and outcome following Iodine-125 implant monotherapy for localised prostate cancer.
    Ash D, Al-Qaisieh B, Bottomley D, Carey B, Joseph J.
    Radiother Oncol; 2005 Jun 01; 75(3):303-6. PubMed ID: 15890423
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. (125)I monotherapy using D90 implant doses of 180 Gy or greater.
    Kao J, Stone NN, Lavaf A, Dumane V, Cesaretti JA, Stock RG.
    Int J Radiat Oncol Biol Phys; 2008 Jan 01; 70(1):96-101. PubMed ID: 17980505
    [Abstract] [Full Text] [Related]

  • 17. Monotherapeutic brachytherapy for clinically organ-confined prostate cancer.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Adamovich E.
    W V Med J; 2005 Jan 01; 101(4):168-71. PubMed ID: 16296198
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.